Progress in the Development of Inhibitors of SH2 Domains

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|6|1|59-98

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.1, 2000-01, pp. : 59-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 17, Iss. 12, 2010-04 ,pp. : 1117-1124

Bentham Science Publishers

Access to resources Recommend Favorite

New inhibitors of SH2-mediated processes

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 3, 1998-03 ,pp. : 333-335

Informa Healthcare

Access to resources Recommend Favorite

Progress in the Development of Matrix Metalloproteinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1388-1395

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Selective Inhibitors of Aurora Kinases

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 199-213

Bentham Science Publishers

Access to resources Recommend Favorite